How much funding has Impel Pharmaceuticals raised?

Impel Pharmaceuticals has raised $148.5M in total funding, most recently a Corporate Round.

Who are Impel Pharmaceuticals's investors?

Impel Pharmaceuticals's investors include Shiv Chaudhary, KKR, 5AM Ventures, Vivo Capital.

When was Impel Pharmaceuticals founded?

Impel Pharmaceuticals was founded in 2008.

Where is Impel Pharmaceuticals headquartered?

Impel Pharmaceuticals is headquartered in Keller, Texas, United States.

What industry is Impel Pharmaceuticals in?

Impel Pharmaceuticals operates in Biotech, Healthcare, Life Sciences.

How many employees does Impel Pharmaceuticals have?

Impel Pharmaceuticals has 51-200 employees.

Impel Pharmaceuticals

IPO

Public · Keller, United States · Founded 2008 · $148.5M raised

Biotech

Healthcare

Life Sciences

Headquarters: Keller, Texas
Employees: 51–200
Founded: 2008
Business Model: B2B2C
Website: impelpharma.com

Total Funding: $148.5M
Last Round: $45.0M Corporate RoundSep 2021
Rounds: 4
Type: Public

About

Impel Pharmaceuticals is a commercial-stage pharmaceutical company pioneering Precision Olfactory Delivery (POD) technology. It administers drug formulations deep into the vascular-rich upper nasal space to improve onset of symptomatic relief for CNS diseases including migraine and Alzheimer's, addressing conditions with high unmet medical needs.

Summary

Impel Pharmaceuticals is a Biotech company based in Keller, United States, founded in 2008. It has raised $148.5M in total across 4 rounds, most recently a $45.0M Corporate Round round in Sep 2021. Investors include Shiv Chaudhary, KKR and 5AM Ventures.

LinkedIn X (Twitter)